Phenotypes of Disseminated Intravascular Coagulation
Thrombosis and Haemostasis · 01.03.2024 · 124 (03) · 181-191
DOI: 10.1055/a-2165-1142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.03.2024. Verfasst von Takeshi Wada und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Division of Acute and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sappo…. Hauptthemen laut MEDLINE: Disseminated Intravascular Coagulation, Thrombosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Two phenotypes of disseminated intravascular coagulation (DIC) are systematically reviewed. DIC is classified into thrombotic and fibrinolytic phenotypes characterized by thrombosis and hemorrhage, respectively. Major pathology of DIC with thrombotic phenotype is the activation of coagulation, insufficient anticoagulation with endothelial injury, and plasminogen activator inhibitor-1-mediated inhibition of fibrinolysis, leading to microvascular fibrin thrombosis and organ dysfunction. DIC with fibrinolytic phenotype is defined as massive thrombin generation commonly observed in any type of DIC, combined with systemic pathologic hyperfibrinogenolysis caused by underlying disorder that results in severe bleeding due to excessive plasmin formation. Three major pathomechanisms of systemic hyperfibrinogenolysis have been considered: (1) acceleration of tissue-type plasminogen activator (t-PA) release from hypoxic endothelial cells and t-PA-rich storage pools, (2) enhancement of the conversion of plasminogen to plasmin due to specific proteins and receptors that are expressed on cancer cells and endothelial cells, and (3) alternative pathways of fibrinolysis. DIC with fibrinolytic phenotype can be diagnosed by DIC diagnosis followed by the recognition of systemic pathologic hyperfibrin(ogen)olysis. Low fibrinogen levels, high fibrinogen and fibrin degradation products (FDPs), and the FDP/D-dimer ratio are important for the diagnosis of systemic pathologic hyperfibrin(ogen)olysis. Currently, evidence-based treatment strategies for DIC with fibrinolytic phenotypes are lacking. Tranexamic acid appears to be one of the few methods to be effective in the treatment of systemic pathologic hyperfibrin(ogen)olysis. International cooperation for the elucidation of pathomechanisms, establishment of diagnostic criteria, and treatment strategies for DIC with fibrinolytic phenotype are urgent issues in the field of thrombosis and hemostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care Medicine, Division of Acute and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
- Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
ORCID-Profile: Takeshi Wada, Satoshi Gando
Förderung
- Japan Society for the Promotion of Science
- JSPS KAKENHI
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Wada, T., & Gando, S. (2024). Phenotypes of Disseminated Intravascular Coagulation. Thrombosis and Haemostasis, 124(03), 181-191. https://doi.org/10.1055/a-2165-1142
Vancouver
Wada T, Gando S. Phenotypes of Disseminated Intravascular Coagulation. Thrombosis and Haemostasis. 2024;124(03):181-191. doi:10.1055/a-2165-1142
BibTeX
@article{Wada2024,
author = {Wada, Takeshi and Gando, Satoshi},
title = {Phenotypes of Disseminated Intravascular Coagulation},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {03},
pages = {181--191},
doi = {10.1055/a-2165-1142}
}
EUVIMED